Literature DB >> 23987145

Stone compositions in Turkey: an analysis according to gender and region.

Osman Raif Karabacak1, Alper Dilli, Hakan Saltaş, Fatih Yalçınkaya, Abdülkerim Yörükoğlu, Memduh Nurettin Sertçelik.   

Abstract

OBJECTIVE: To evaluate the compositions of the kidney stones obtained from different regions of Turkey and to present the gender and regional differences.
METHODS: The study included 6453 kidney stones obtained from patients from different parts of Turkey. All of the stones were obtained using ureterorenoscopy, percutaneous stone surgery, laparoscopic or open stone surgery, or extracorporeal shock wave lithotripsy. X-ray diffraction crystallography method was used for analysis.
RESULTS: At the end of the analysis, 11 different stone types including calcium oxalate (Ca-ox) monohydrate (whewellite, COM), Ca-ox dihydrate (weddellite, COD), uric acid, cystine, struvite, biurea, xanthine brushite, quartz, whitlockite, and dahlite were determined either in pure or mixed conditions. Of the stones, 80.4% were Ca-ox (55.7% COM, 5.9% COD, 18.8% COM + COD), 4.8% uric acid, 3.1% cystine, and 3.3% were phosphate stones (dahlite, brushite, struvite, whitlockite). The remaining 8.4% of the stones were in mixed form with different combinations. Of the patients, 4411 were men (68.3%) and 2042 were women (31.7%).
CONCLUSION: Ca-ox was the most frequently encountered stone type in our country as it is worldwide. The distribution of the other stone types is different than the other countries. The information about the structure of the stone has significant contribution to the understanding of the stone formation etiology, programming of the treatment process, and prevention of the recurrences. The study is significant in presenting the stone profile of Turkey.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23987145     DOI: 10.1016/j.urology.2013.04.059

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Prevalence of renal uric acid stones in the adult.

Authors:  Alberto Trinchieri; Emanuele Montanari
Journal:  Urolithiasis       Date:  2017-03-03       Impact factor: 3.436

2.  Silicate calculi, a rare cause of kidney stones in children.

Authors:  Mehmet Taşdemir; Dilara Fuçucuoğlu; Oktay Özman; Lale Sever; Bülent Önal; Ilmay Bilge
Journal:  Pediatr Nephrol       Date:  2016-10-05       Impact factor: 3.714

3.  The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.

Authors:  Angela Guerra; Andrea Ticinesi; Franca Allegri; Antonio Nouvenne; Silvana Pinelli; Giuseppina Folesani; Fulvio Lauretani; Marcello Maggio; Loris Borghi; Tiziana Meschi
Journal:  Urolithiasis       Date:  2016-04-01       Impact factor: 3.436

4.  Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.

Authors:  Felix Grases; Adrian Rodriguez; Antonia Costa-Bauza
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

5.  The relationship between kidney stones and dietary habits.

Authors:  Akeel T Al-Kazwini; Maan S Al-Arif; Suhad S Abu-Mweis; Tarek F Al-Hammouri
Journal:  Res Rep Urol       Date:  2019-07-25

6.  Editorial Comment: Upper urinary tract stone compositions: the role of age and gender.

Authors:  Fábio C M Torricelli
Journal:  Int Braz J Urol       Date:  2020 Jan-Feb       Impact factor: 1.541

7.  Influence of Age and Geography on Chemical Composition of 98043 Urinary Stones from the USA.

Authors:  Jonathan E Katz; Nachiketh Soodana-Prakash; Anika Jain; Madhumita Parmar; Nicholas Smith; Oleksandr Kryvenko; Glenn W Austin; Hemendra N Shah
Journal:  Eur Urol Open Sci       Date:  2021-10-28

8.  Kidney stones among Iranian adults: Prevalence and socioeconomic inequality assessment in a cohort-based cross-sectional study.

Authors:  Telma Zahirian Moghadam; Farhad Pourfarzi; Hamed Mohseni Rad; Hamed Zandian
Journal:  Health Sci Rep       Date:  2022-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.